TrialClinical pharmacokinetics2007

Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV maturation, in healthy volunteers.

David E Martin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.